Literature DB >> 30846069

Adrenergic Overstimulation: A Neglected Mechanism of Sepsis-Related Cardiomyopathy.

Daniele Orso1, Roberto Copetti2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30846069      PMCID： PMC6435898          DOI： 10.1016/j.chest.2018.09.032

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  4 in total

1.  Infusion of esmolol attenuates lipopolysaccharide-induced myocardial dysfunction.

Authors:  Zenggeng Wang; Qinghua Wu; Xiangbi Nie; Jinghua Guo; Chunli Yang
Journal:  J Surg Res       Date:  2015-07-14       Impact factor: 2.192

2.  Infusion of the beta-adrenergic blocker esmolol attenuates myocardial dysfunction in septic rats.

Authors:  Takeshi Suzuki; Hiroshi Morisaki; Ryohei Serita; Michiko Yamamoto; Yoshifumi Kotake; Akitoshi Ishizaka; Junzo Takeda
Journal:  Crit Care Med       Date:  2005-10       Impact factor: 7.598

Review 3.  The Septic Heart: Current Understanding of Molecular Mechanisms and Clinical Implications.

Authors:  Lukas Martin; Matthias Derwall; Sura Al Zoubi; Elisabeth Zechendorf; Daniel A Reuter; Chris Thiemermann; Tobias Schuerholz
Journal:  Chest       Date:  2018-08-29       Impact factor: 9.410

Review 4.  Pathophysiology of sepsis-related cardiac dysfunction: driven by inflammation, energy mismanagement, or both?

Authors:  Konstantinos Drosatos; Anastasios Lymperopoulos; Peter Johannes Kennel; Nina Pollak; P Christian Schulze; Ira J Goldberg
Journal:  Curr Heart Fail Rep       Date:  2015-04
  4 in total
  1 in total

1.  Myocardial effects of angiotensin II compared to norepinephrine in an animal model of septic shock.

Authors:  Bruno Garcia; Fuhong Su; Laurence Dewachter; Raphaël Favory; Amina Khaldi; Alexander Moiroux-Sahraoui; Filippo Annoni; Francisco Vasques-Nóvoa; Estela Rocha-Oliveira; Roberto Roncon-Albuquerque; Geraldine Hubesch; Hassane Njimi; Jean-Louis Vincent; Fabio S Taccone; Jacques Creteur; Antoine Herpain
Journal:  Crit Care       Date:  2022-09-18       Impact factor: 19.334
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.